Invest in Cancer Stocks

Invest in Cancer Stocks

Author: Eric Shea Broadus

Publisher: WestBow Press

Published: 2023-01-18

Total Pages: 119

ISBN-13: 1664287892

DOWNLOAD EBOOK

If you like investing in stocks and hate cancer, then why not build wealth by investing in companies dedicated to fighting the disease? Eric Shea Broadus, a cancer survivor and the founder of an investment advisory firm, draws on his decades of experience in the financial arena to help investors make money while supporting a great cause. Learn how to: • determine who to consult when making investment decisions; • identify publicly traded companies that are waging war against cancer; • evaluate investments based on key metrics; • establish and track investment goals. Throughout the book, the author highlights why supporting companies that are seeking to fight, treat, and cure cancer is so important, as well as the lessons he learned battling cancer. Companies dedicated to fighting cancer and bolstering the immune system are making a significant difference for millions of current and future cancer patients and have produced wonderful financial returns for many investment portfolios. Learn how to build a profitable portfolio consisting of oncology stocks, health insurance stocks, and real estate investment trusts related to cancer treatment with this guide.


Delivering Affordable Cancer Care in the 21st Century

Delivering Affordable Cancer Care in the 21st Century

Author: Institute of Medicine

Publisher: National Academies Press

Published: 2013-06-20

Total Pages: 95

ISBN-13: 030926944X

DOWNLOAD EBOOK

Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness.In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop.


Valuation in Life Sciences

Valuation in Life Sciences

Author: Boris Bogdan

Publisher: Springer Science & Business Media

Published: 2010-04-19

Total Pages: 378

ISBN-13: 3642108202

DOWNLOAD EBOOK

Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art. In the following chapters we will provide the user with a concise val- tion manual, providing transparency and practical insight for all dealing with valuation in life sciences: project and portfolio managers, licensing executives, business developers, technology transfer managers, entrep- neurs, investors, and analysts. The purpose of the book is to explain how to apply discounted cash flow and real options valuation to life sciences p- jects, i.e. to license contracts, patents, and firms. We explain the fun- mentals and the pitfalls with case studies so that the reader is capable of performing the valuations on his own and repeat the theory in the exercises and case studies. The book is structured in five parts: In the first part, the introduction, we discuss the role of the players in the life sciences industry and their p- ticular interests. We describe why valuation is important to them, where they need it, and the current problems to it. The second part deals with the input parameters required for valuation in life sciences, i.e. success rates, costs, peak sales, and timelines.


Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services

Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services

Author: Les Funtleyder

Publisher: McGraw Hill Professional

Published: 2008-12-31

Total Pages: 289

ISBN-13: 0071642951

DOWNLOAD EBOOK

Is your portfolio in peak health? Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for investment gain.” Health-Care Investing provides a thorough explanation of how the industry's mammoth size and complexity can be worked to your advantage and why health care is more resistant to changes in economic cycles than other markets. Funtleyder gives you a comprehensive overview of the industry, from both macro and micro points of view, so you can make informed decisions regarding your investments. You'll find critical information concerning The natural inelasticity of health care and how to profit from it How to take advantage of the market's complexities and inefficiencies Issues and policy changes you need to know The social responsibility aspect of investing in health care Why this market is essential for diversified portfolios In Health-Care Investing, Funtleyder provides the tools you need to dig up the richest opportunities possible and build them into your investment strategy. You'll get a detailed look at traditional market patterns and the events that have shaped--and will continue to shape--the industry. Then you'll find specific strategies you can use to maximize your profits, whether you invest in pharma, biotech, managed services, or a combination of them. This informative and practical guide also includes a list of questions you can use as an investment “template,” which will help guide your decision-making process. With Health Care Investing, you'll be armed with the know-how to make the right decisions today in order to fully capitalize on events of the future.


Assessing and Improving Value in Cancer Care

Assessing and Improving Value in Cancer Care

Author: Institute of Medicine

Publisher: National Academies Press

Published: 2009-11-30

Total Pages: 164

ISBN-13: 0309138140

DOWNLOAD EBOOK

Unlike many other areas in health care, the practice of oncology presents unique challenges that make assessing and improving value especially complex. First, patients and professionals feel a well-justified sense of urgency to treat for cure, and if cure is not possible, to extend life and reduce the burden of disease. Second, treatments are often both life sparing and highly toxic. Third, distinctive payment structures for cancer medicines are intertwined with practice. Fourth, providers often face tremendous pressure to apply the newest technologies to patients who fail to respond to established treatments, even when the evidence supporting those technologies is incomplete or uncertain, and providers may be reluctant to stop toxic treatments and move to palliation, even at the end of life. Finally, the newest and most novel treatments in oncology are among the most costly in medicine. This volume summarizes the results of a workshop that addressed these issues from multiple perspectives, including those of patients and patient advocates, providers, insurers, health care researchers, federal agencies, and industry. Its broad goal was to describe value in oncology in a complete and nuanced way, to better inform decisions regarding developing, evaluating, prescribing, and paying for cancer therapeutics.


The Investment Answer

The Investment Answer

Author: Gordon Murray

Publisher: Business Plus

Published: 2011-01-12

Total Pages: 88

ISBN-13: 1455503290

DOWNLOAD EBOOK

What if there were a way to cut through all the financial mumbo-jumbo? Wouldn't it be great if someone could really explain to us-in plain and simple English-the basics we must know about investing in order to insure our financial freedom? At last, here's good news. Jargon-free and written for all investors-experienced, beginner, and everyone in between-The Investment Answer distills the process into just five decisions-five straightforward choices that can lead to safe and sound ways to manage your money. When Wall Street veteran Gordon Murray told his good friend and financial advisor, Dan Goldie, that he had only six months to live, Dan responded, "Do you want to write that book you've always wanted to do?" The result is this eminently valuable primer which can be read and understood in one sitting, and has advice that benefits you, not Wall Street and the rest of the traditional financial services industry. The Investment Answer asks readers to make five basic but key decisions to stack the investment odds in their favor. The advice is simple, easy-to-follow, and effective, and can lead to a more profitable portfolio for every investor. Specifically: Should I invest on my own or seek help from an investment professional? How should I allocate my investments among stocks, bonds, and cash? Which specific asset classes within these broad categories should I include in my portfolio? Should I take an actively managed approach to investing, or follow a passive alternative? When should I sell assets and when should I buy more? In a world of fast-talking traders who believe that they can game the system and a market characterized by instability, this extraordinary and timely book offers guidance every investor should have.


Science Business

Science Business

Author: Gary P. Pisano

Publisher: Harvard Business Press

Published: 2006

Total Pages: 278

ISBN-13: 9781591398400

DOWNLOAD EBOOK

Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.


Magic Cancer Bullet

Magic Cancer Bullet

Author: Daniel Vasella, M.D.

Publisher: Harper Collins

Published: 2003-06-03

Total Pages: 274

ISBN-13: 0060010304

DOWNLOAD EBOOK

History of the breakthrough of the cancer pill "Gleevec."


Cancer Control Opportunities in Low- and Middle-Income Countries

Cancer Control Opportunities in Low- and Middle-Income Countries

Author: Institute of Medicine

Publisher: National Academies Press

Published: 2007-01-26

Total Pages: 340

ISBN-13: 030913398X

DOWNLOAD EBOOK

Cancer is low or absent on the health agendas of low- and middle-income countries (LMCs) despite the fact that more people die from cancer in these countries than from AIDS and malaria combined. International health organizations, bilateral aid agencies, and major foundations—which are instrumental in setting health priorities—also have largely ignored cancer in these countries. This book identifies feasible, affordable steps for LMCs and their international partners to begin to reduce the cancer burden for current and future generations. Stemming the growth of cigarette smoking tops the list to prevent cancer and all the other major chronic diseases. Other priorities include infant vaccination against the hepatitis B virus to prevent liver cancers and vaccination to prevent cervical cancer. Developing and increasing capacity for cancer screening and treatment of highly curable cancers (including most childhood malignancies) can be accomplished using "resource-level appropriateness" as a guide. And there are ways to make inexpensive oral morphine available to ease the pain of the many who will still die from cancer.


Gene Marcial's 7 Commandments of Stock Investing

Gene Marcial's 7 Commandments of Stock Investing

Author: Gene G. Marcial

Publisher: FT Press

Published: 2008-03-26

Total Pages: 224

ISBN-13: 0132703432

DOWNLOAD EBOOK

“Gene Marcial provides iconoclastic insights into the art of successful investing while exploding the mythology of the conventional wisdom. His 7 Commandments of Stock Investing is scintillating reading for both individual and institutional investors who seek an advantage in their moneymaking endeavors.” --Scott Black, President of Delphi Management Inc. and a member of the Barron’s Roundtable “It is well understood that trading in the stock market is full of risks. But if you are ready to take the plunge, I guarantee that there will be a time when being familiar with Gene Marcial’s 7 Commandments of Stock Investing will be extremely important. Over the years, I have followed many of the same commandments.” --Carl Icahn, Chairman, Icahn Associates “This book begins with one of the wisest investment observations I’ve ever encountered: ‘There are plenty of ways to make money in the stock market, but clinging to mainstream thinking or so-called conventional wisdom is not one of them.’ The author’s discussion on avoiding the diversification trap is alone worth many times the price of this book.” --Bernie Schaeffer, Chairman, Schaeffer’s Investment Research, Inc., www.SchaeffersResearch.com “Gene Marcial has been guiding literally millions of investors to better financial performance over his more than 30 years as a leading financial journalist. He consistently has demonstrated a rare instinct for knowing when to follow a trend and when to think like a contrarian. In today’s turbulent times, his new book, 7 Commandments of Stock Investing, is essential reading for all investors and could well add precious percentage points to the performance of any who take his words to heart.” --Stephen Leeb, President, Leeb Capital Management Inc. Every week, the investment world turns to Gene Marcial’s BusinessWeek column. Here’s why: Marcial knows how to pick winners. Apple at 15. US Steel at 19. But Marcial’s track record isn’t limited to just one or two picks. In fact, recent analysis reveals that he’s beaten the indexes for a full decade. You can’t get results like that following the “conventional wisdom”! You need to know what Gene Marcial has learned about stock investing--and this book will tell you. Marcial has distilled 35 years of experience into seven powerful, counterintuitive “commandments”: rules that are simple and practical enough for every investor to profit from. Marcial reveals why diversification is not an optimal investment strategy...why you need to focus on finding big winners, and how you can...how to profit from panic, and how to lock in your profits when everyone else is “fat and happy.” Along the way, he opens up the secret, mysterious world of corporate and market insiders--showing how to track them down, emulate their approaches, and profit from their lucrative strategies. Be prepared to profit from panic Plot a clear strategy to seize opportunities during a macro-market panic Learn how to “buy the losers” Finding tomorrow’s big winners in today’s bargain bin Profit from the unknown Finding investments that are undervalued because investors don’t understand them The “sweet seven”: specific stock picks for the next seven years What to buy right now--and hold for the long term